StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CRAV.PA$164.76+2.15%
Fair $164.76+0.0%

CRAV.PA

Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée

Financial Services / Banks - RegionalParis

$164.76

+3.48 (+2.15%)

Fairly Valued+0.0%Fair Value $164.76Fund rank 24/100 · Data gapFallback financials|
SA 42/C
F-Score: 3/9
Low Profitability

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 9.0/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 0/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

42/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. ROE is 2.0%, below the 5% threshold
Thesis & Journal · CRAV.PALocal privado en este navegador · Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.2B

P/E

14.2x

↑

EV/EBITDA

N/A

•

ROE

2.0%

↓

Gross Margin

N/A

•

Debt/Equity

0.07

↓
52-Week Range$165
$99$168

TradingView lightweight chart

CRAV.PA price, volumen y niveles de valoración

Último $165.50Periodo +122.6%
Fair value: $164.76

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-4.3%

FCF CAGR

—

FCF margin

-133.9%

FCF / Net income

-6.77x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $432.1M · net income $85.5M · FCF $-578.4M

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

19.8%-7.1% pts

FCF margin

-133.9%-105.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$432.1M$432.1M$425.4M$413.2M$493.6M
Net Income$85.5M$85.5M$85.6M$86.4M$132.9M
EPS11.5811.5811.5911.7017.99
Net Margin19.8%19.8%20.1%20.9%26.9%
Balance Sheet
Debt/Equity0.070.070.090.120.17
Cash Flow
Free Cash Flow$-578.4M$-578.4M$229.8M$-903.2M$-139.7M
Returns
ROE2.0%2.0%2.1%2.3%3.7%
Valuation
P/E14.2214.227.587.184.28
P/B0.280.280.160.170.16
Growth & Yield
Revenue Growth1.6%1.6%2.9%-16.3%—
EPS Growth-0.1%-0.1%-0.9%-35.0%—
Dividend Yield2.3%2.3%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

8.1%

razonable

EPS terminal req.

$14.62

Spread vs growth

-8.2%

5Y implied EPS CAGR

8.8%

razonable

EPS terminal req.

$17.69

Spread vs growth

-8.9%

10Y implied EPS CAGR

9.4%

razonable

EPS terminal req.

$28.49

Spread vs growth

-9.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +65.1%

Total return

+65.1%

Start / end P/E

8.8x → 14.3x

EPS bridge

11.59 → 11.58

Residual

-0.1%

EPS growth-0.1%
Multiple rerating+62.9%
Dividend+2.3%
Residual / FX / buybacks / cross-term-0.1%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.